Clinical Trials in Pharmaceutical Development: Trends and Challenges
American Journal of Pharmaceutics · 31.10.2022 · 3 (5) · 13-21
DOI: 10.71465/ajph2175 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pharmaceutics, online erschienen am 31.10.2022. Verfasst von Dr. Ayesha Khan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clinical trials are pivotal in the pharmaceutical development process, serving as the bridge between laboratory research and clinical application. This article examines current trends and challenges in clinical trials, emphasizing the impact of technological advancements, regulatory complexities, and patient-centric approaches. The integration of artificial intelligence (AI), real-world data (RWD), and adaptive trial designs are reshaping trial methodologies. However, issues such as recruitment difficulties, ethical considerations, and high attrition rates persist. Addressing these challenges requires innovative strategies and collaborative efforts across the healthcare ecosystem.
Zitieren
APA
Khan, D. A. (2022). Clinical Trials in Pharmaceutical Development: Trends and Challenges. American Journal of Pharmaceutics, 3(5), 13-21. https://doi.org/10.71465/ajph2175
Vancouver
Khan DA. Clinical Trials in Pharmaceutical Development: Trends and Challenges. American Journal of Pharmaceutics. 2022;3(5):13-21. doi:10.71465/ajph2175
BibTeX
@article{Khan2022,
author = {Khan, Dr. Ayesha},
title = {Clinical Trials in Pharmaceutical Development: Trends and Challenges},
journal = {American Journal of Pharmaceutics},
year = {2022},
volume = {3},
number = {5},
pages = {13--21},
doi = {10.71465/ajph2175}
}
EUVIMED